Results 161 to 170 of about 2,821 (202)
Some of the next articles are maybe not open access.

Physostigmine for Antimuscarinic Toxicity

Journal of Emergency Nursing, 2020
Raghad Saadi, Kristin Bohnenberger
openaire   +2 more sources

Antimuscarinics and Cognitive Function

European Urology, 2006
In recent years antimuscarinics have been studied extensively after decades of silence. For many years oxybutynin formed the cornerstone of the treatment for overactive bladder (OAB). Currently, trospium chloride, tolterodine, solifenacin, and darifenacin have made it to the market.
openaire   +1 more source

Antimuscarinics in multiple sclerosis: A systematic review

Multiple Sclerosis and Related Disorders
Multiple sclerosis (MS) is an immune-mediated disease, impacting the central nervous system, resulting in a wide range of symptoms. Lower urinary tract symptoms (LUTS) are one of the common symptoms in MS patients and antimuscarinic drugs (AMs) are suggested as the first-line treatment in MS-related LUTS. This systematic review evaluates any impacts of
Afra Darvishi   +9 more
openaire   +2 more sources

Antimuscarinic drugs.

Professional nurse (London, England), 2004
Antimuscarinic drugs are used to treat urinary incontinence and increase bladder capacity in both children and adults. Carol McLoughlin looks at when they should be prescribed, the adverse reactions to be aware of, and how to help patients use them properly as part of their ...
openaire   +1 more source

Antimuscarinic Effects of Lithium

New England Journal of Medicine, 1984
S, Kanba, E, Richelson
openaire   +2 more sources

Antimuscarinic activity of aprophen

Biochemical Pharmacology, 1983
R K, Gordon   +4 more
openaire   +2 more sources

Safety of Physostigmine for Pediatric Antimuscarinic Poisoning

Journal of Medical Toxicology
Physostigmine fell out of widespread use in the 1980s due to safety concerns; however, more recent research has demonstrated that its safety profile is better than previously thought. These studies have mainly included adults. We theorized that improved safety data may lead to more acceptance.
Sarah Huber   +4 more
openaire   +2 more sources

Comparative Safety of Antimuscarinics Versus Mirabegron for Overactive Bladder in Parkinson Disease

Parkinsonism and Related Disorders, 2023
Allison Willis   +2 more
exaly  

Antimuscarinics

2016
Bernadette Prentice   +2 more
openaire   +1 more source

Home - About - Disclaimer - Privacy